maximum percent increase for each patient after the test drug on each of the three days. On day 1, the response of the FEV, to fenoterol was better than that to ephedrine to a highly significant degree ( P < 0.01) at all times from one to six hours (Fig 1 ) . This degree of difference was found at two, three. and four hours on day 45, and only at three and four hours on day 90 (Fig 2) . The responses of the FEF,,.,, to fenoterol and ephedrine differed to a similar degree. The specific conductance (Caw/VL) increased by 83 percent two hours after fenoterol on day 1, and 88 percent on day 45. However. on day 90, the maximum increase was less (74 percent) and later (three hours). By contrast, the maximum response to ephedrine was higher (25 percent) on day 90 than on day 1 (16 percent). The differences between the response of the c a w / V~ to the two drugs were highly significant on day 1 and 2, 3, and 5 hours, but by day 90 were only moderately significant ( P < six hours on day 1, and five hours on the last day. The mean time to maximum response was 2.38 hours oo day 1 and 2.58 hours on the last day. The side effects are listed in Table 2 . Eleven of the 15 patients who received fenoterol experienced nervousness and tremor, but this was serious enough to terminate the study in only one. Four others required a tranquilizer, and five noted that the side effects diminished or disap peared during the k t month of trealment.
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Ephedrine maximum percent increase for each patient after the test drug on each of the three days. On day 1, the response of the FEV, to fenoterol was better than that to ephedrine to a highly significant degree ( P < 0.01) at all times from one to six hours (Fig 1 ) . This degree of difference was found at two, three. and four hours on day 45, and only at three and four hours on day 90 (Fig 2) . The responses of the FEF,,.,, to fenoterol and ephedrine differed to a similar degree. The specific conductance (Caw/VL) increased by 83 percent two hours after fenoterol on day 1, and 88 percent on day 45. However. on day 90, the maximum increase was less (74 percent) and later (three hours). By contrast, the maximum response to ephedrine was higher (25 percent) on day 90 than on day 1 (16 percent). The differences between the response of the c a w / V~ to the two drugs were highly significant on day 1 and 2, 3, and 5 hours, but by day 90 were only moderately significant ( P < six hours on day 1, and five hours on the last day. The mean time to maximum response was 2.38 hours oo day 1 and 2.58 hours on the last day. The side effects are listed in Table 2 . Eleven of the 15 patients who received fenoterol experienced nervousness and tremor, but this was serious enough to terminate the study in only one. Four others required a tranquilizer, and five noted that the side effects diminished or disap peared during the k t month of trealment.
It is clear that fenoterol is a much more potent bronchodilator than is ephedrine. However, there was a significant reduction in its d e c t on ventilatory function during the course of the study, associated with an increased tolerance regarding side effects in about half the subjects.
Another interesting 6nding was that the baseline ventilatory function dropped substantially between day 1 and day 45 (Fig 3) . This change (fenoterol and ephedrine) was significant ( P < .05). AU the subjects had been instructed not to take any oral adrenergic drug for a four-week "washout" period before starting the study. It is possible, then, that the drop in baseline values was due to a reduction in responsiveness to endogenous bronchodilators.
Crossover Study with Nebulized Bronchodilators and Atropine
Roger H. L. Wilson, M.D.; Patricia J. Battaglia; and Nancy L. Wilson F ifteen patients with chronic asthmatic bronchitis and emphysema were studied in a doubleblind crossover between isoproterenol and fenoterol approximately duee months continuously oq each, using two inhalations from a metered dose inhaler three to four times daily. All showed a repeated 20 percent or better improvement on spirornetric testing with isoproterenol prior to the study. Pulmonary function measurements were obtained on each patient at two weekly intervals; the lapse rate was negligible. Spirometry and plethysmography was performed prior to a dose, then at one minute (spimmetry only), 20 minutes, and hourly to six hours. No significant ~e p n " t repwe*: Dr. Wilson, 500 Spme, S u e 204, Son FmnciPco 94118
CHEST 73: 6. JUNE, 1978 SUPPLEMENT W8 WORKSHOP NO. 4 differences were found between the values at the start fall of about 50 percent from the peak improvement is and end of each h g regimen, although the baseline of associated with a feeling of need on the patient's part for individuals tested influenced the response.
remedication. For this reason we analyzed each reparate Gmuped means show a sigdcant improvement in all start, peak and curve in relation to the specific 50 spirometxic measurements with isoproterenol greater percent improvement value. The d t s (Table 1 ) than fenoteml at one minute, and a consistent si&-showed an extreme significance paralleling ow previous cantly greater response to fenoterol compared to isoprohdings with the exception of V,,.
terenol at one, two, three, and four hours with a nonsigEkven of the patients participated in additional six nificant advantage for fenoteml at Eve and six hours. The how testing of nebulized boproterenol, fenoterol and fenoterol peak response was noted to appear at one how, metaproterenol with co-administration of 1/150 gr of oral isoproterenol at one minute. However, fenoteml essenatropine. Grouped means show a sigdcant improvement tially equalled the isopmterenol peak at 20 minutes.
in spirometric measurements for: 1) isoproterewl+ a h Comparing the results obtained during each of the pine through three hours of testing over isopmtemol months of the crossover study, no signilicant differences alone; 2) fenoteml + atropine through six hours over of patient response could be observed. There was a fa& fenoteml alone; and 3) metap&erenol+ a h p i n e mainoff in responze at day 45 in some patients which was taiwd a greater than 20 percent increase in each meastatistically sigruficant; these, however, promptly resurement through four hours. (Metapmterenol alone was tuned to the original levels. Therefore, tachyphylaxis or not tested). Grouped means of specific conductance show similar problems do not appear to be important in the improvement for: 1 ) isoproterenol + atropine through selection of this agent in the patient requiring chronic three hours over isoproterenol alone; 2) fenoterol + therapy with a beta, agonist. More important in evaluatatropine at two, three, four, five, and six hours over ing response is starting point on any one day. A profound fenoteml done; and 3 ) metapmterenol + atropine mainsignilicanoe in percentage change can be seen between tained effectiveness (greater than 40 percent increase) studies depending on whether the starting point lies through four hours. Total respiratory resistance values below or above the mean for a specifc patient's grouped (Lexington) show an advantage for: 1) isop&erenol + initial values in any parameter. atropine at 20 minutes; 2) fenoterol + atropine at two It has been noted previously in this laboratory that a hours; and 3 ) metaproterenol + atropine at two h o w . In these patients the addition of oral atropine increased the duration of improvement in F'EV,., of is* proterenol alone from one hour to three, and of fenoteml from four hours to six; metaproterenol with atropine functioned effectively as a bronchodilator through four hours.
T.bb I-chi
Pooled data in 18 patients including a previous study of metapmterenol and isoproterenol (these 15 patients included) provides an interesting comparison of these three bronchodilators: isoproterenol showing F'EV,., improvement over 20 percent at one and 20 minutes; metaprotereno1 at one minute, 20 minutes, m e and two hours; and fenoterol at 20 minutes, one, two, three, and four hours.
It is therefore inferred that metaproterenol shows an important advantage over isoproterenol, and that fen* teml shows an important advantage over metapmterenol in h e a h e n t of these patients. The addition of atropine potentiates each drug. There are unresolved questionz as to which flow or resistance parameter of pulmonary function should be c h m for optimal demonstration of bronchodilator responsiveness. For example, the percentage of improvement in specific conductance as determined by body pletheysmography is usually much greater than that of flow measurements from spiromeky. Accepting these and other pitfalls in methodology and analysis, I will present relatively simple data from our studies. Figure 1 depicts the results of three months of adrninh a t i o n of randomly assigned either ephedrine or Thll65a (fenoterol p r o t e c ] ) to 28 asthmatic subjects in a protocol identical to others being presented in this workshop and previously published (Simi WW, Miller 
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